GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » Scaled Net Operating Assets

Anti-Microbialvior BioteQ Co (ROCO:6864) Scaled Net Operating Assets : 0.26 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Anti-Microbialvior BioteQ Co's operating assets for the quarter that ended in Dec. 2024 was NT$54.05 Mil. Anti-Microbialvior BioteQ Co's operating liabilities for the quarter that ended in Dec. 2024 was NT$8.48 Mil. Anti-Microbialvior BioteQ Co's Total Assets for the quarter that ended in Jun. 2024 was NT$174.60 Mil. Therefore, Anti-Microbialvior BioteQ Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.26.


Anti-Microbialvior BioteQ Co Scaled Net Operating Assets Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co Scaled Net Operating Assets Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.63 0.36 0.20 0.24 0.36

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.22 0.28 0.28 0.37 0.26

Competitive Comparison of Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets falls into.


;
;

Anti-Microbialvior BioteQ Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(54.049-8.48)/128.047
=0.36

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=248.176 - 194.127
=54.049

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.866 - 0.194 - 2.192
=8.48

Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Jun. 2024 )
=(54.049-8.48)/174.602
=0.26

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=248.176 - 194.127
=54.049

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.866 - 0.194 - 2.192
=8.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines